![Helix BioPharma Company (PK)](/common/images/company/NO_HBPCF.png)
Helix BioPharma is a biopharmaceutical company specializing in the field of cancer therapy. The Company is developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's clinical product development initiatives include Topical Interferon Alph... Helix BioPharma is a biopharmaceutical company specializing in the field of cancer therapy. The Company is developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's clinical product development initiatives include Topical Interferon Alpha-2b, for the treatment of conditions caused by the human papilloma virus. Helix is also developing its novel L-DOS47 new drug product candidate for the treatment of lung adenocarcinoma. Show more
Saratoga Investment Corp., Formerly GSC Investment Corp., Completes Recapitalization $55 million of new equity and debt cures loan default, Provides capital to grow middle-market lending PR...
GSC Investment Corp. Reminds Stockholders to Vote at July 30th Special Meeting Stockholders Urged to Vote FOR Proposals Relating to Critical Recapitalization Plan Today PR Newswire NEW YORK, July...
Leading Independent Proxy Advisory Firms Recommend that Stockholders of GSC Investment Corp. Vote "FOR" Proposals Relating to Recapitalization Plan at July 30th Special Meeting ISS and Glass...
GSC Investment Corp. Announces First Quarter Fiscal Year 2011 Financial Results PR Newswire NEW YORK, July 15 NEW YORK, July 15 /PRNewswire-FirstCall/ -- GSC Investment Corp. (NYSE: GNV), a...
GSC Investment Corp. to Report Q1 2011 Financial Results on July 15th PR Newswire NEW YORK, July 1 NEW YORK, July 1 /PRNewswire-FirstCall/ -- GSC Investment Corp. (the "Company") (NYSE: GNV...
GSC Investment Corp. Announces Filing and Mailing of Definitive Proxy Statement for Special Meeting of Stockholders Special Meeting of Stockholders to be Held on July 30, 2010 to Vote on...
GSC Investment Corp. Announces Fourth Quarter and Fiscal Year 2010 Financial Results PR Newswire NEW YORK, May 28 NEW YORK, May 28 /PRNewswire-FirstCall/ -- GSC Investment Corp. (NYSE: GNV), a...
GSC Investment Corp. Schedules Earning Release of Fourth Quarter and Fiscal Year 2010 Financial Results PR Newswire NEW YORK, May 24 NEW YORK, May 24 /PRNewswire-FirstCall/ -- GSC Investment...
GSC Investment Corp. Enters Into Definitive Agreement with Saratoga Investment Advisors, LLC Announces $55 million recapitalization plan to cure debt default PR Newswire NEW YORK, April 14 NEW...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0.1662 | 0.1662 | 0.1662 | 1000 | 0.1662 | CS |
12 | 0 | 0 | 0.1662 | 0.1662 | 0.1662 | 1000 | 0.1662 | CS |
26 | 0.0249 | 17.6220806794 | 0.1413 | 0.1662 | 0.1377 | 970 | 0.15037533 | CS |
52 | 0.0249 | 17.6220806794 | 0.1413 | 0.1662 | 0.1377 | 970 | 0.15037533 | CS |
156 | -0.5388 | -76.4255319149 | 0.705 | 0.723474 | 0.1377 | 981 | 0.3114119 | CS |
260 | -0.3501 | -67.8094131319 | 0.5163 | 1.1481 | 0.1377 | 1592 | 0.54081767 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.